Tumor Necrosis Factor-α Inhibitor Use Is Not Associated with Lipid Changes in Rheumatoid Arthritis

被引：4

作者：

Bili, Androniki ^{[1
]}

Morris, Stephanie J. ^{[1
]}

Sartorius, Jennifer A. ^{[1
]}

Kirchner, H. Les ^{[1
]}

Antohe, Jana L. ^{[1
]}

Dancea, Sorina ^{[1
]}

Wasko, Mary Chester ^{[1
]}

机构：

[1] Geisinger Hlth Syst, Dept Rheumatol, Danville, PA 17822 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2012年 / 39卷 / 05期

关键词：

RHEUMATOID ARTHRITIS; LIPIDS; TUMOR NECROSIS FACTOR-alpha INHIBITORS; INFLIXIMAB TREATMENT; INSULIN-RESISTANCE; PROFILE; THERAPY; PATTERNS;

D O I：

10.3899/jrheum.111093

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To determine the association of use of tumor necrosis factor-alpha (TNF-alpha) inhibitors with differences in lipid levels in patients with rheumatoid arthritis (RA). Methods. We studied 807 patients with incident RA to compare differences in lipid levels in TNF-alpha inhibitor users versus nonusers, with adjustment for relevant covariables. Results. TNF-alpha inhibitor use was not associated with differences in levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), triglycerides, LDL:HDL, or TC:HDL compared to nonusers. Conclusion. Use of TNF-alpha inhibitor was not associated with differences in lipid levels in patients with RA. (First Release April 1 2012; J Rheumatol 2012;39:946-8; doi:10.3899/jrheum.111093)

引用

页码：946 / 948

页数：3

共 50 条

[41] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis
Kavanaugh, AF
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 593 - +
[42] Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
Desai, Rishi J.
Rao, Jaya K.
Hansen, Richard A.
Fang, Gang
Maciejewski, Matthew L.
Farley, Joel F.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (11): : 1110 - 1120
[43] Graves' Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy
Shin, Jae Il
Kim, Min Jung
Lee, Jae Seung
JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 449 - 450
[44] Tumor necrosis factor-α microsatellite polymorphism association with rheumatoid arthritis in Indian patients
Agrawal, C
Raghav, SK
Gupta, B
Das, RH
Chaturvedi, VP
Goswami, K
Das, HR
ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (05) : 555 - 559
[45] Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
Yang, Nicole
Huang, Jie
Frits, Michelle
Iannaccone, Christine
Weinblatt, Michael E.
Rifai, Nader
Shadick, Nancy
Bradwin, Gary
Liao, Katherine P.
PRACTICAL LABORATORY MEDICINE, 2019, 16
[46] The gene polymorphism of tumor necrosis factor-β, but not that of tumor necrosis factor-α, is associated with the prognosis of sarcoidosis
Yamaguchi, E
Itoh, A
Hizawa, N
Kawakami, Y
CHEST, 2001, 119 (03) : 753 - 761
[47] Systematic Review of Tumor Necrosis Factor Inhibitor Discontinuation Studies in Rheumatoid Arthritis
Navarro-Millan, Iris
Sattui, Sebastian E.
Curtis, Jeffrey R.
CLINICAL THERAPEUTICS, 2013, 35 (11) : 1850 - 1861
[48] Perforating folliculitis associated with tumour necrosis factor-α inhibitors administered for rheumatoid arthritis
Gilaberte, Y.
Coscojuela, C.
Vazquez, C.
Rosello, R.
Vera, J.
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) : 368 - 371
[49] Tumor necrosis factor-α inhibitor-associated psoriasis: Facts and hypotheses
Luo, Feng
Lee, Yung-Heng
Ma, Wu-kai
Yong, Su-Boon
Yao, Xue-ming
Wei, James Cheng-Chung
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (06) : 1011 - 1014
[50] Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis
Perpetuo, Ines P.
Caetano-Lopes, Joana
Rodrigues, Ana Maria
Campanilho-Marques, Raquel
Ponte, Cristina
Canhao, Helena
Ainola, Mari
Fonseca, Joao E.
BIOMED RESEARCH INTERNATIONAL, 2017, 2017

← 1 2 3 4 5 →